Oscar Health, Inc.

NYSE:OSCR

Medical - Healthcare Plans

Healthcare
$27.57 +0.18%

+$0.05 today

Market cap
$7.15B
Beta
2.39
P/E (TTM)
-214.2
EPS (TTM)
-$0.13
52W Low $10.69High $29.81

Volume 7.38M

Average 7.51M

OSCR Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Oscar Health, Inc.NYSE: OSCR

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue remains negative

Q2 FY2026 cost of revenue was $0, compared with $2.55B a year earlier. Trailing-twelve-month cost of revenue was $8.44B.

Context

  • Cost of revenue amounted to 85.6% of revenue in FY2025, up 5.7 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly cost of revenue holds near $0 or moves back toward the trailing-twelve-month quarterly average of $2.11B.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$10.02B+36.6% YoY
LTMJun 2026
$8.44B+22.7% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year+36.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
10.02B USD
Year-over-year change
+36.6%

Cost of Revenue vs competitors

How OSCR compares with its peers on the latest reported figures

  • OSCR's LTM Jun 2026 cost of revenue of $8.44B is the 6th highest of the 8 companies compared; the peer median is $128.05B.
  • Its year-over-year change of +22.7% is the 3rd highest of 8, against a peer median of +6.5%.
  • Cost of revenue amounts to 55.1% of revenue for OSCR, versus a peer median of 85.8%.
OSCR Competitors Peer median
Cost of Revenue for OSCR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CVSCVS Health CorporationLTM Jun 2026$356.34B +6.9%+9.0%85.8%
CICigna CorporationLTM Sep 2026$256.93B +6.5%+16.6%89.7%
CNCCentene CorporationLTM Jun 2026$162.49B +0.1%+10.2%83.9%
ELVElevance Health Inc.LTM Sep 2026$128.05B -10.9%+8.3%63.4%
MOHMolina Healthcare, Inc.LTM Sep 2026$40.11B +0.1%+13.8%91.9%
OSCROscar Health, Inc.LTM Jun 2026$8.44B +22.7%—55.1%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$3.73B +40.5%+40.4%87.6%
CLOVClover Health Investments, Corp.LTM Jun 2026$2.02B +64.7%+16.5%81.4%
Peer median (excluding OSCR) $128.05B+6.5%+13.8%85.8%

Competitors are the stored peer set for OSCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.92B4.13B5.86B9.18B11.7B
Cost of Revenue004.64B7.33B10.02B
Gross Profit1.92B4.13B1.22B1.84B1.68B
Gross Margin100.0%100.0%20.8%20.1%14.4%
Research & Development00000
Selling, General & Admin265.08M1.42B002.05B
Operating Expenses2.49B4.74B1.46B1.79B2.08B
Depreciation & Amortization14.61M15.28M30.69M32.15M28.89M
EBITDA(551.26M)(572.17M)(212M)89.31M(391.05M)
EBITDA Margin-28.7%-13.9%-3.6%1.0%-3.3%
Operating Income(570.58M)(610.08M)(235.62M)57.27M(396.36M)
Operating Margin-29.7%-14.8%-4.0%0.6%-3.4%
Interest Income00000
Interest Expense4.72M22.62M24.6M23.73M17.6M
Other Income / Expenses00(31.69M)(23.84M)(40.94M)
Income Before Tax(570.58M)(610.08M)(267.3M)33.43M(437.3M)
Pre-Tax Margin-29.7%-14.8%-4.6%0.4%-3.7%
Income Tax Expense846K(523K)3.29M7.31M5.61M
Net Income(572.61M)(606.28M)(270.73M)25.43M(443.15M)
Net Margin-29.8%-14.7%-4.6%0.3%-3.8%
EPS (Basic)(3.19)(2.85)(1.22)0.11(1.69)
EPS (Diluted)(3.19)(2.85)(1.22)0.10(1.69)
Weighted Avg Shares178.97M212.47M221.66M240.39M262.39M
Weighted Avg Shares (Diluted)178.97M212.47M221.66M265.85M262.39M

Oscar Health, Inc.

NYSE:OSCR

Intrinsic Alpha fair value

Locked

Current Price

$27.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.